SCHEMBL1396281

SCHEMBL1396281

CCCCC(N)N(CC)CC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.40
PLA2G1B P04054 1/20 0.40
PLA2G2A P14555 1/20 0.40
ALDH1A1 P00352 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
DNM1 Q05193 2/20 0.36
SPHK1 Q9NYA1 2/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
SLC1A3 P43003 1/20 0.33
SLC1A2 P43004 1/20 0.33
SLC1A1 P43005 1/20 0.33
DPP7 Q9UHL4 1/20 0.32
SLC15A1 P46059 1/20 0.32
TP53 P04637 2/20 0.32
LAP3 P28838 1/20 0.32
CYP2D6 P10635 2/20 0.31
GMNN O75496 1/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2845824 0.92 OPRM1 (0.50) OPRM1PLA2G1BPLA2G2ASPHK1SLC1A2
SCHEMBL8751118 0.90 PLA2G1B (0.52) OPRM1PLA2G1BPLA2G2ADNM1SPHK1
SCHEMBL20678370 0.90 PLA2G1B (0.52) OPRM1PLA2G1BPLA2G2ADNM1SPHK1
SCHEMBL18315357 0.90 PLA2G1B (0.52) OPRM1PLA2G1BPLA2G2ADNM1SPHK1
SCHEMBL187299 0.83 PLA2G1B (0.33) OPRM1PLA2G1BPLA2G2A
SCHEMBL7187154 0.82 PLA2G1B (0.39) OPRM1PLA2G1BPLA2G2AALDH1A1TDP1
SCHEMBL20774234 0.82 PLA2G1B (0.39) OPRM1PLA2G1BPLA2G2AALDH1A1TDP1
SCHEMBL10679647 0.82 DNM1 (0.32) PLA2G1BPLA2G2AALDH1A1DNM1
SCHEMBL27863177 0.80 GSR (0.37) OPRM1PLA2G1BPLA2G2AALDH1A1DNM1
SCHEMBL25062934 0.80 PLA2G1B (0.35) OPRM1PLA2G1BPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109554004-B Pigment dispersants and their use 江苏丽王科技股份有限公司 2024-02-20 CN claimed
CN-112225697-A Preparation method of enantiomer pure chloroquine and chloroquine phosphate 宁波大学 2021-01-15 CN claimed
EP-2764860-A1 Cupuassu fatty acid amidoamines and their derivatives BASF SA (BR) 2014-08-13 EP claimed
US-12528948-B2 Amino (meth)acrylates ALLNEX BELGIUM S.A. (BE) 2026-01-20 US disclosed
US-20250009920-A1 Monitoring System Based on Etching of Metals JP LABORATORIES INC. 2025-01-09 US disclosed
CN-109554004-B Pigment dispersants and their use 江苏丽王科技股份有限公司 2024-02-20 CN disclosed
US-11828660-B2 UV cured indicating devices JP LABORATORIES, INC. (US) 2023-11-28 US disclosed
EP-3293493-B1 STERILIZATION INDICATING DEVICE JP LABORATORIES INC (US) 2023-06-14 EP disclosed
US-20230151222-A1 AMINO (METH)ACRYLATES ALLNEX BELGIUM S.A. (BE) 2023-05-18 US disclosed
CN-112225697-B Preparation method of enantiomer pure chloroquine and chloroquine phosphate 宁波大学 2023-01-03 CN disclosed
CN-110621653-B Amino (meth) acrylates 湛新比利时股份有限公司 2022-09-16 CN disclosed
US-20010027239-A1 Ozonolysis of unsaturated polyolefins in alcohol-hydrocarbon mixture forming polyolefin-alkoxyhydroperoxides which are reduced to form hemiacetals and hemiketals, then aminating and removing catalyst; halogen-free; fuel/oil adjuvants AKZO NOBEL NV (NL) 2001-10-04 US disclosed
US-20010025124-A1 Dissolving 3-butene-1,2-diol in alkanol; ozonolysis AKZO NOBEL N.V. (NL) 2001-09-27 US disclosed
WO-2001062696-A1 PROCESS FOR THE PREPARATION OF GLYCERALDEHYDE AND DERIVATIVES THEREOF AKZO NOBEL N.V. (NL) 2001-08-30 WO disclosed
WO-2001055229-A1 PROCESS TO MAKE AMINATED POLYOLEFINS AKZO NOBEL N.V. (NL) 2001-08-02 WO disclosed
US-6177144-B1 Binder and its use in radiation-curable coating agents BASF COATINGS AG (DE) 2001-01-23 US disclosed
US-5792827-A RADIATION CURABLE ADDITION PRODUCTS OF OLIGOMERS HAVING AT LEAST TWO ACRYLIC ESTER GROUPS, POLYAMINES BASF LACKE + FARBEN, AG (DE) 1998-08-11 US disclosed
EP-0342439-A2 Process for the aftertreatment of dyed textile materials BAYER AG (DE) 1989-11-23 EP disclosed
EP-0056766-B1 PROCESS FOR THE PREPARATION OF 4-AMINO-CHLOROQUINOLINES RHONE-POULENC SANTE (FR) 1984-05-16 EP disclosed
EP-0056766-A1 Process for the preparation of 4-amino-chloroquinolines RHONE-POULENC SANTE (FR) 1982-07-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12528948-B2 Amino (meth)acrylates MAT2B, MAT1A, MMAB OPRM1 2289/4885PLA2G1B 2637/4885PLA2G2A 3005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.